Treatmentcom International Stock Performance
| TREIF Stock | USD 0.57 0.00 0.00% |
On a scale of 0 to 100, TreatmentCom International holds a performance score of 6. The entity has a beta of -0.3, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning TreatmentCom International are expected to decrease at a much lower rate. During the bear market, TreatmentCom International is likely to outperform the market. Please check TreatmentCom International's jensen alpha, semi variance, market facilitation index, as well as the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether TreatmentCom International's existing price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TreatmentCom International are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, TreatmentCom International reported solid returns over the last few months and may actually be approaching a breakup point. ...more
TreatmentCom |
TreatmentCom International Relative Risk vs. Return Landscape
If you would invest 51.00 in TreatmentCom International on September 29, 2025 and sell it today you would earn a total of 6.00 from holding TreatmentCom International or generate 11.76% return on investment over 90 days. TreatmentCom International is currently producing 0.4226% returns and takes up 5.5247% volatility of returns over 90 trading days. Put another way, 49% of traded otc stocks are less volatile than TreatmentCom, and 92% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
TreatmentCom International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TreatmentCom International's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as TreatmentCom International, and traders can use it to determine the average amount a TreatmentCom International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0765
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TREIF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average TreatmentCom International is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TreatmentCom International by adding it to a well-diversified portfolio.
TreatmentCom International Fundamentals Growth
TreatmentCom OTC Stock prices reflect investors' perceptions of the future prospects and financial health of TreatmentCom International, and TreatmentCom International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TreatmentCom OTC Stock performance.
| Return On Equity | -78.21 | |||
| Return On Asset | -4.53 | |||
| Current Valuation | 2.28 M | |||
| Shares Outstanding | 66.22 M | |||
| Price To Book | 209.92 X | |||
| EBITDA | (13.9 M) | |||
| Cash And Equivalents | 251.62 K | |||
| Total Debt | 184.01 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (6.29 M) | |||
| Earnings Per Share | (0.17) X | |||
| Total Asset | 942.51 K | |||
About TreatmentCom International Performance
By analyzing TreatmentCom International's fundamental ratios, stakeholders can gain valuable insights into TreatmentCom International's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TreatmentCom International has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TreatmentCom International has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Treatment.Com International Inc. provides personalized health care information services in Canada. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada. Treatment International is traded on OTC Exchange in the United States.Things to note about TreatmentCom International performance evaluation
Checking the ongoing alerts about TreatmentCom International for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for TreatmentCom International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TreatmentCom International is not yet fully synchronised with the market data | |
| TreatmentCom International had very high historical volatility over the last 90 days | |
| TreatmentCom International has some characteristics of a very speculative penny stock | |
| TreatmentCom International has high likelihood to experience some financial distress in the next 2 years | |
| TreatmentCom International has accumulated 184.01 K in total debt. TreatmentCom International has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist TreatmentCom International until it has trouble settling it off, either with new capital or with free cash flow. So, TreatmentCom International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TreatmentCom International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TreatmentCom to invest in growth at high rates of return. When we think about TreatmentCom International's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (13.86 M) with loss before overhead, payroll, taxes, and interest of (656.4 K). | |
| TreatmentCom International has accumulated about 251.62 K in cash with (6.29 M) of positive cash flow from operations. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing TreatmentCom International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TreatmentCom International's stock is overvalued or undervalued compared to its peers.
- Examining TreatmentCom International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TreatmentCom International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TreatmentCom International's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of TreatmentCom International's otc stock. These opinions can provide insight into TreatmentCom International's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for TreatmentCom OTC Stock analysis
When running TreatmentCom International's price analysis, check to measure TreatmentCom International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TreatmentCom International is operating at the current time. Most of TreatmentCom International's value examination focuses on studying past and present price action to predict the probability of TreatmentCom International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TreatmentCom International's price. Additionally, you may evaluate how the addition of TreatmentCom International to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |